VectraCor Receives Vizient Innovative Technology Contract
Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization’s care delivery and business model.
VectraplexECG with CEB Our Smartest ECG
Introducing the VectraplexECG, the first ECG device to derive a 15-22 lead ECG using only 5-electrodes and CEB® technology to detect a potential heart attack.
Orbit™ Spirometer
Portable PC-based spirometer with Pre-calibrated mouthpieces
Universal ECG™
Our most cost effective portable PC-based 12-lead ECG with interpretation
Detects ECG changes suggestive of a heart attack.
Allows you to email an ECG report to anyone
We connect to most major EMR systems.

What we do?

VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack and derive a 15-22 lead ECG utilizing only 5-electrodes. We have a entire suite of products that are durable, mobile, and ready to turn an off-the-shelf tablet or laptop into a medical device. Our products are FDA cleared, CE marked, and VectraCor is
ISO-13485 certified.


People in the U.S have heart attacks each year


People die each year from a heart attack


Have a heart attack for the first time each year


Have recurrent heart attacks

Heart Disease Stroke and Research Statisitcs At-a-Glance by American Heart Association


We have a range of products to get you started whether you are an urgent care, primary care, or hospital.

Complete the form to request a demo